Journal articleEur J Cancer2013
Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancer.
- Journal
- Eur J Cancer
- Published
- 30 April 2013
- Citations
- 143
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Trials 2
- Its registry lists this paper as resultsAflibercept Compared to Placebo in Term of Efficacy in Patients Treated With Gemcitabine for Metastatic Pancreatic Canc… NCT00574275↗
- BackgroundA Phase II Clinical Trial of Fruquintinib as Third Line Treatment in Advanced Pancreatic Cancer NCT05257122↗
The registry lists these as results papers; in a hand check of 27 such links about 78% reported the trial’s results, so read the paper before treating it as the outcome.